Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

Cited by (399)

Items 101–200 of 399

1. Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior
   Zuzanna Misiewicz, Stella Iurato, Natalia Kulesskaya, Laura Salminen, Luis Rodrigues, Giuseppina Maccarrone, Jade Martins, Darina Czamara, Mikaela A. Laine, Ewa Sokolowska et al. · 2019 · PLoS Genetics
2. Nutrient-Based Therapies for Bipolar Disorder: A Systematic Review
   L. Sylvia, A. Peters, T. Deckersbach, A. Nierenberg · 2012 · Psychotherapy and Psychosomatics
3. Agomelatine in Depressive Disorders: Its Novel Mechanisms of Action
   Venkataramanujan Srinivasan, Rahimah Zakaria, Zahiruddin Othman, Edward C. Lauterbach, Darı́o Acuña-Castroviejo · 2012 · Journal of Neuropsychiatry
4. Mitochondria DNA copy number, mitochondria DNA total somatic deletions, Complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder
   Sujan C. Das, B. Hjelm, B. Rollins, A. Sequeira, Ling Z. Morgan, A. A. Omidsalar, A. Schatzberg, J. Barchas, F. Lee, R. Myers et al. · 2022 · Translational Psychiatry
5. Bipolar disorder dynamics: affective instabilities, relaxation oscillations and noise
   Michael B. Bonsall, John Richard Geddes, Guy M. Goodwin, Emily Alexandra Holmes · 2015 · Journal of The Royal Society Interface
6. Mapping pathologic circuitry in schizophrenia
   Jill R. Glausier, David A. Lewis · 2018 · Handbook of clinical neurology
7. Ketogenic diet for schizophrenia
   Zóltan Sarnyai, Ann-Katrin Kraeuter, Christopher Palmer · 2019 · Current Opinion in Psychiatry
8. mRNA changes in nucleus accumbens related to methamphetamine addiction in mice
   Li Zhu, Jiaqi Li, Nan Dong, Fanglin Guan, Yufeng Liu, Dongliang Ma, Eyleen L. K. Goh, Teng Chen · 2016 · Scientific Reports
9. Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis
   Kuo-Chuan Huang, Ko-Chun Yang, Han Lin, Theresa Tsun-Hui Tsao, Sheng‐An Lee · 2014 · BMC Genomics
10. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Toniolo, Ricardo Alexandre, Silva, Michelle, Fernandes, Francy de Brito Ferreira, Amaral, José Antonio de Mello Siqueira, Dias, Rodrigo da Silva, Lafer, Beny · 2018 · Journal of Neural Transmission
11. Cognitive effects of creatine monohydrate adjunctive therapy in patients with bipolar depression: Results from a randomized, double-blind, placebo-controlled trial
    Toniolo, Ricardo Alexandre, Fernandes, Francy de Brito Ferreira, Silva, Michelle, Dias, Rodrigo da Silva, Lafer, Beny · 2017 · Journal of Affective Disorders
12. NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia
    Oded Bergman, Rachel Karry, Jumana Milhem, Dorit Ben‐Shachar · 2018 · Molecular Psychiatry
13. Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
    Qian Chen, Ting Cao, Nana Li, Cuirong Zeng, Shuangyang Zhang, Xiangxin Wu, Bikui Zhang, Hualin Cai · 2021 · Frontiers in Pharmacology
14. Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment
    Parvin Kumar, Paschalis Efstathopoulos, Vincent Millischer, Eric Olsson, Ya Bin Wei, Oliver Brüstle, Martin Schalling, J. Carlos Villaescusa, Urban Ösby, Catharina Lavebratt · 2018 · Scientific Reports
15. Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophrenia
    Alexandre Duarte Gigante, Ana C. Andreazza, Beny Lafer, Lakshmi N. Yatham, Clare L. Beasley, Lionel Trevor Young · 2011 · Neuroscience Letters
16. Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic‐pituitary‐adrenal axis and immune system
    Anne Cecilia Duffy, Ute Lewitzka, Sarah Doucette, Ana C. Andreazza, Paul Grof · 2011 · Early Intervention in Psychiatry
17. Novel Complex Interactions between Mitochondrial and Nuclear DNA in Schizophrenia and Bipolar Disorder
    Anton Schulmann, Euijung Ryu, Vanessa Faria Gonçalves, Brandi L. Rollins, Michael Christiansen, Mark A. Frye, Joanna M. Biernacka, Marquis P. Vawter · 2019 · Complex Psychiatry
18. Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state
    Vittorio Calabrese, James Giordano, Rosalia Crupi, Rosanna Di Paola, Martino Ruggieri, Rio Bianchini, Maria Laura Ontario, Salvatore Cuzzocrea, Edward J. Calabrese · 2016 · Journal of Neuroscience Research
19. Methylene blue and its analogues as antidepressant compounds
    Anzelle Delport, Brian Herbert Harvey, Anél Petzer, Jacobus Petrus Petzer · 2017 · Metabolic Brain Disease
20. Bioenergetic Measurements in Children with Bipolar Disorder: A Pilot 31P Magnetic Resonance Spectroscopy Study
    Elif Muazzez Şıkoğlu, John Eric Jensen, Gordana D. Vitaliano, Ana A. Liso Navarro, Perry Franklin Renshaw, Jean A. Frazier, Constance M. Moore · 2013 · PLoS ONE
21. Oxidative Stress and Emergence of Psychosis
    Victoria Rambaud, Aude Marzo, Boris Chaumette · 2022 · Antioxidants
22. Mitochondrial Dysfunction, Altered Mitochondrial Oxygen, and Energy Metabolism Associated with the Pathogenesis of Schizophrenia
    Iveta Fizíková, Jozef Dragašek, Peter Račay · 2023 · International Journal of Molecular Sciences
23. Histone deacetylase inhibitors reverse manic-like behaviors and protect the rat brain from energetic metabolic alterations induced by ouabain
    Jéssica Lopes-Borges, Samira Silva Valvassori, Roger B. Varela, Paula T. Tonin, Júlia S. Vieira, Cinara Ludvig Gonçalves, Emilio Luiz STRECK, João Quevedo · 2014 · Pharmacology Biochemistry and Behavior
24. Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation
    Estefanía Piñero-Martos, Bernardo Ortega-Vila, Josep Pol-Fuster, Eugenia Cisneros Barroso, Laura Ruiz-Guerra, Aina Medina-Dols, Damián Heine‐Suñer, Jerònia Lladó, Gabriel Olmos, Cristòfol Vives-Bauzá · 2016 · Human Molecular Genetics
25. Decreased Brain pH and Pathophysiology in Schizophrenia
    Hae Jeong Park, Inyeong Choi, Kang‐Hyun Leem · 2021 · International Journal of Molecular Sciences
26. Gray Matter Volumetric Abnormalities Associated with the Onset of Psychosis
    Wi Hoon Jung, Stefan Borgwardt, Paolo Fusar‐Poli, Jun Soo Kwon · 2012 · Frontiers in Psychiatry
27. Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain
    Valvassori, Samira S., Dal-Pont, Gustavo C., Steckert, Amanda V., Varela, Roger B., Lopes-Borges, Jéssica, Mariot, Edemilson, Resende, Wilson R., Arent, Camila O., Carvalho, André F., Quevedo, João · 2016 · Psychiatry Research
28. Regional differences in mitochondrial DNA methylation in human post-mortem brain tissue
    Matthew A.M. Devall, Rebecca G. Smith, Aaron R. Jeffries, Eilis J. Hannon, Matthew N Davies, Leonard C. Schalkwyk, Jonathan S. Mill, Michael N. Weedon, Katie Lunnon · 2017 · Clinical Epigenetics
29. Mitochondria dysfunction and bipolar disorder: From pathology to therapy
    Xin-Jieh Lam, Bingzhe Xu, Pei Ling Yeo, Pike-See Cheah, King‐Hwa Ling · 2023 · IBRO Neuroscience Reports
30. Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients
    Ebubekir Dirican, Halil Özcan, Sevgi Karabulut Uzunçakmak, Uğur Takım · 2023 · Clinical Psychopharmacology and Neuroscience
31. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder
    Maria Jalbrzikowski, María T. Lázaro, Fuying Gao, Alden Huang, Carolyn C. Chow, Daniel H. Geschwind, Giovanni Coppola, Carrie E. Bearden · 2015 · PLoS ONE
32. Sex-dependent mental illnesses and mitochondria
    Akiko Shimamoto, Virginie Rappeneau · 2017 · Schizophrenia Research
33. Mitochondrial function in individuals at clinical high risk for psychosis
    Tania Da Silva, Abbie Wu, Isabelle Laksono, Ivana Prce, Margaret Maheandiran, Michael Kiang, A. Andreazza, R. Mizrahi · 2018 · Scientific Reports
34. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity
    Dana Felker, Alexandra Lynn, Sue Wang, Dale E. Johnson · 2014 · Expert Review of Clinical Pharmacology
35. Permeability Transition Pore-Mediated Mitochondrial Superoxide Flashes Regulate Cortical Neural Progenitor Differentiation
    Hou, Yan, Mattson, Mark P., Cheng, Aiwu · 2013 · PLoS ONE
36. Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
    Daniella Dwir, Inès Khadimallah, Lijing Xin, Meredith Rahman, Fei Du, Döst Öngür, Kim Q. · 2023 · The International Journal of Neuropsychopharmacology
37. Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine
    Gustavo Feier, Samira Silva Valvassori, Jéssica Lopes-Borges, Roger B. Varela, Daniela Vicente Bavaresco, Giselli Scaini, Meline Oliveira dos Santos Morais, Mônica L. Andersen, Emilio Luiz STRECK, João Quevedo · 2012 · Neuroscience Letters
38. Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder
    Martina Zvěřová, Jana Hroudová, Zdeněk Fišar, Hana Hansíková, Lucie Kališová, Eva Kitzlerová, Alena Lambertová, Jiří Raboch · 2019 · Neuropsychiatric Disease and Treatment
39. Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
    Walter H. Moos, Eleni Maneta, Carl A. Pinkert, Michael H. Irwin, Michelle E. Hoffman, Douglas V. Faller, Kosta Steliou · 2016 · Drug Development Research
40. Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology
    Data-Franco, João, Singh, Ajeet, Popovic, Dina, Ashton, Melanie, Berk, Michael, Vieta, Eduard, Figueira, M.L., Dean, Olivia M. · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
41. Progress in defining the biological causes of schizophrenia
    Ben S. Pickard · 2011 · Expert Reviews in Molecular Medicine
42. Transcranial Infrared Laser Stimulation Improves Cognition in Older Bipolar Patients: Proof of Concept Study
    Courtney M. O’Donnell, Douglas W. Barrett, Latham H. L. Fink, Erica Cristina Garcia-Pittman, Francisco Gonzalez-Lima · 2021 · Journal of Geriatric Psychiatry and Neurology
43. Serum metabolic profiling using small molecular water‐soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre–post‐treatment design
    Bing Cao, Min Jin, Elisa Macedo Brietzke, Roger S. McIntyre, Dongfang Wang, Joshua Daniel Rosenblat, Renee‐Marie Ragguett, Chuanbo Zhang, Xiaoyu Sun, Carola Rong et al. · 2018 · Psychiatry and Clinical Neurosciences
44. Brain cytochrome‐c‐oxidase as a marker of mitochondrial function: A pilot study in major depression using NIRS
    Lisa Holper, Martin J. Lan, Patrick J. Brown, M. Elizabeth Sublette, Ainsley K. Burke, John J. Mann · 2019 · Depression and Anxiety
45. Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model
    Filiou, Michaela D., Teplytska, Larysa, Otte, David M., Zimmer, Andreas, Turck, Christoph W. · 2012 · Journal of Psychiatric Research
46. Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis
    Abigail Stein, Chenyanwen Zhu, Fei Du, Döst Öngür · 2023 · Current Psychiatry Reports
47. Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects
    Galila Agam, Lilah Toker · 2015 · Neuropsychiatric Disease and Treatment
48. Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders
    Ana C. Andreazza · 2012 · Molecular BioSystems
49. Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: Implications for striatal energy metabolism
    Emily Booth Warren, Aidan Aicher, Joshua P. Fessel, Christine L. Konradi · 2017 · PLoS ONE
50. Abnormal Brain Bioenergetics in First-Episode Psychosis
    Çağrı Yüksel, Xi Chen, Virginie‐Anne Chouinard, Lisa D. H. Nickerson, Margaret Gardner, Talia Rachel Cohen, Döst Öngür, Fei Du · 2021 · Schizophrenia Bulletin Open
51. Mitochondrial dysfunction in schizophrenia: an evolutionary perspective
    Vanessa Faria Gonçalves, Ana C. Andreazza, James L. Kennedy · 2014 · Human Genetics
52. Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons
    Gustavo Scola, Helena Kyunghee Kim, Lionel Trevor Young, Mirian Mendonça Salvador, Ana C. Andreazza · 2014 · Psychopharmacology
53. Differentiating patients with schizophrenia from healthy controls by hippocampal subfields using radiomics
    Yae Won Park, Dongmin Choi, Joonho Lee, Sung Soo Ahn, Seung‐Koo Lee, Sang‐Hyuk Lee, Minji Bang · 2020 · Schizophrenia Research
54. Lithium acts to modulate abnormalities at behavioral, cellular, and molecular levels in sleep deprivation‐induced mania‐like behavior
    Mutahar Andrabi, Muatar Maknoon Andrabi, Remesh Kunjunni, Mukesh K. Sriwastva, Samrat Bose, Rajesh Sagar, Achal Kumar Srivastava, Rashmi Mathur, Suman Jain, Vivekanandhan Subbiah · 2019 · Bipolar Disorders
55. Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction
    Ricarda Breitmeyer, Sabrina Vogel, Johanna Heider, Sophia-Marie Hartmann, Richard Wüst, Anna‐Lena Keller, Anna Binner, Julia Catherine Fitzgerald, Andreas Jochen Fallgatter, Hansjürgen Volkmer · 2023 · Communications Biology
56. Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder
    Gabriel R. Fries, Mirela Paiva Vasconcelos-Moreno, Carolina Gubert, Bárbara Tietbohl-Santos, André Luiz Schuh Teixeira da Rosa, Barbara Schneider Eisele, Juliana Sartori, Bianca Pfaffenseller, Flávio Pereira Kapczinski, Marcia Kauer‐Sant’Anna · 2013 · Journal of Affective Disorders
57. Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: A literature overview.
    S. Schiavone, L. Trabace · 2016 · Pharmacological Research
58. Mitochondrial Dysfunction Is Inducible in Lymphoblastoid Cell Lines From Children With Autism and May Involve the TORC1 Pathway
    Sirish C. Bennuri, Shannon Rose, Richard E. Frye · 2019 · Frontiers in Psychiatry
59. What is bipolar disorder? A disease model of dysregulated energy expenditure
    Rodrigo Barbachan Mansur, Yena L. Lee, Roger S. McIntyre, Elisa Macedo Brietzke · 2020 · Neuroscience & Biobehavioral Reviews
60. Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer
    James S. Brown · 2022 · Neuroscience & Biobehavioral Reviews
61. Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review
    Anna Giménez‐Palomo, H. Andreu Gracia, Oscar de Juan, Luis Olivier, Iñaki Ochandiano, Lídia Ilzarbe, Marc Valentí, Aldo Stoppa, Cristian-Daniel Llach, Giulio Pacenza et al. · 2024 · Brain Sciences
62. Mitochondria under the spotlight: On the implications of mitochondrial dysfunction and its connectivity to neuropsychiatric disorders
    Mara Zilocchi, Kirsten Broderick, Sadhna Phanse, Khaled Ahmed Aly, Mohan Babu · 2020 · Computational and Structural Biotechnology Journal
63. Proteomic Analysis of Lymphoblastoid Cells Derived from Monozygotic Twins Discordant for Bipolar Disorder: A Preliminary Study
    An‐a Kazuno, Kenji Ohtawa, Kaori Otsuki, Masaya Usui, Hiroko Sugawara, Yuji Okazaki, Tadafumi Kato · 2013 · PLoS ONE
64. Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia
    Luiz Silva, Mariana Dutra Brito, Jéssica Mayumi Camargo Yuzawa, Tatiana Rosado Rosenstock · 2019 · Scientific Reports
65. Inborn errors of metabolism associated with psychosis: literature review and case–control study using exome data from 5090 adult individuals
    Yannis J Trakadis, Vanessa Fulginiti, Mark Walterfang · 2017 · Journal of Inherited Metabolic Disease
66. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches
    Juliana C. Corrêa-Velloso, Maria CB Gonçalves, Yahaira Naaldijk, Ágatha Oliveira‐Giacomelli, Micheli Mainardi Pillat, Henning Ulrich · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
67. Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia
    Jinyoung Choi, Jiseung Kang, Tae Kim, Christa J. Nehs · 2024 · Frontiers in Psychiatry
68. The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
    Adriano José Maia Chaves Filho, Capri Eyres, Leonie Blöbaum, Antonia Landwehr, Marie‐Ève Tremblay · 2024 · Journal of Neurochemistry
69. Modeling mitochondrial dysfunctions in the brain: from mice to men
    Megan E. Breuer, Peter H.G.M. Willems, Frans G. M. Rüssel, Werner J.H. Koopman, Jan A.M. Smeitink · 2011 · Journal of Inherited Metabolic Disease
70. Experiencing community and domestic violence is associated with epigenetic changes in DNA methylation of <i>BDNF</i> and <i>CLPX</i> in adolescents
    Serpeloni, Fernanda, Nätt, Daniel, Assis, Simone Gonçalves de, Wieling, Elizabeth, Elbert, Thomas · 2020 · Psychophysiology
71. Mitochondrial roles of the psychiatric disease risk factor DISC1
    Rosalind Norkett, Souvik Modi, Josef T. Kittler · 2017 · Schizophrenia Research
72. Gene expression study of mitochondrial complex I in schizophrenia and paranoid personality disorder
    Arvin Haghighatfard, Sarah Andalib, Mozhdeh Amini Faskhodi, Soha Sadeghi, Amir Hossein Ghaderi, Shadi Moradkhani, Jalal Rostampour, Zeinab Tabrizi, Ali Mahmoodi, Talie Karimi et al. · 2017 · The World Journal of Biological Psychiatry
73. DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?
    Piotr Lech Czarny, Katarzyna I. Białek, Sylwia Ziółkowska, Justyna Strycharz, Tomasz Śliwiński · 2019 · Mutagenesis
74. Entangled radicals may explain lithium effects on hyperactivity
    Hadi Zadeh‐Haghighi, Christoph Simon · 2021 · Scientific Reports
75. Ketogenic diet in therapy of bipolar affective disorder - case report and literature review
    Ireneusz Chmiel · 2021 · Psychiatria Polska
76. Clozapine influences cytoskeleton structure and calcium homeostasis in rat cerebral cortex and has a different proteomic profile than risperidone
    Sylwia Kędracka–Krok, Bianka Świderska, Urszula Jankowska, Bożena Skupień-Rabian, Joanna Solich, Katarzyna Buczak, Marta Dziedzicka‐Wasylewska · 2014 · Journal of Neurochemistry
77. Upstream Pathways Controlling Mitochondrial Function in Major Psychosis
    Alencar Kolinski Machado, Alexander Yongshuai Pan, Tatiane Morgana da Silva, Angela Duong, Ana C. Andreazza · 2016 · The Canadian Journal of Psychiatry
78. Mitochondrial proteomics investigation of frontal cortex in an animal model of depression: Focus on chronic antidepressant drugs treatment
    Katarzyna Głombik, Aneta Stachowicz, Ewa Trojan, Joanna Ślusarczyk, Maciej Suski, Katarzyna Chamera, Katarzyna Kotarska, Rafał Olszanecki, Agnieszka Basta‐Kaim · 2017 · Pharmacological Reports
79. Proton Transport Chains in Glucose Metabolism: Mind the Proton
    Dirk Roosterman, Wolfgang Meyerhof, Graeme Stuart Cottrell · 2018 · Frontiers in Neuroscience
80. Placental mitochondrial DNA content is associated with childhood intelligence
    Esmée M. Bijnens, Catherine A Derom, Steven Weyers, Bram G. Janssen, Evert W. Thiery, Tim S. Nawrot · 2019 · Journal of Translational Medicine
81. Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study
    Eloi Giné-Servén, Maria Martinez-Ramirez, Ester Boix-Quintana, Eva Daví-Loscos, Nicolau Guanyabens, Virginia Casado, Desirée Muriana, Cristina Torres Rivas, Benedicto Crespo‐Facorro, Javier Labad · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
82. Metal Nanoparticle Modified Carbon-Fiber Microelectrodes Enhance Adenosine Triphosphate Surface Interactions with Fast-Scan Cyclic Voltammetry
    Yuxin Li, Alexandra L. Keller, Michael T. Cryan, Ashley E. Ross · 2021 · ACS Measurement Science Au
83. Altered Coupling of Regional Cerebral Blood flow and Brain Temperature in Schizophrenia Compared with Bipolar Disorder and Healthy Subjects
    Miho Ota, Noriko Sato, Koji Sakai, Mitsutoshi Okazaki, Norihide Maikusa, Kotaro Hattori, Hiroaki Hori, Toshiya Teraishi, Keigo Shimoji, Kei Yamada et al. · 2014 · Journal of Cerebral Blood Flow & Metabolism
84. Reduced mRNA Expression of PTGDS in Peripheral Blood Mononuclear Cells of Rapid-Cycling Bipolar Disorder Patients Compared with Healthy Control Subjects
    Klaus Munkholm, Lone Peijs, Lars Vedel Kessing, Maj Vinberg · 2014 · The International Journal of Neuropsychopharmacology
85. Açaí (Euterpe oleracea Mart.) as a Potential Anti-neuroinflammatory Agent: NLRP3 Priming and Activating Signal Pathway Modulation
    Francine Carla Cadoná, Diulie Valente de Souza, Tuyla Fontana, David Frederick Bodenstein, Andiara Prates Ramos, Michele Rorato Sagrillo, Mirian Mendonça Salvador, Kennya Marcia dos Santos Mota, Carolina Bordin Davidson, Euler Esteves Ribeiro et al. · 2021 · Molecular Neurobiology
86. Selfish brain and neuroprogression in bipolar disorder.
    R. Mansur, D. Cha, E. Asevedo, R. McIntyre, E. Brietzke · 2013 · Progress in Neuro-psychopharmacology and Biological Psychiatry
87. Leveraging ultra-high field (7T) MRI in psychiatric research
    Finnegan J. Calabro, Ashley C. Parr, Valerie J. Sydnor, Hoby P. Hetherington, Konasale M. R. Prasad, Tamer S. Ibrahim, Deepak K. Sarpal, Alyssa Famalette, Piya Verma, Beatríz Luna · 2024 · Neuropsychopharmacology
88. Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia
    Constanza Morén, David Olivares-Berjaga, Albert Martínez-Pinteño, Miquel Bioque, Natàlia Rodríguez, Patricia Gassó, Lourdes Martorell, Eduard Parellada · 2025 · International Journal of Molecular Sciences
89. Lactate levels in the brain and blood of schizophrenia patients: A systematic review and meta-analysis
    Senqi Liu, Luwen Zhang, Xiaoyun Fan, Guanyu Wang, Qing Liu, Yongfeng Yang, Minglong Shao, Meng Song, Wenqiang Li, Luxian Lv et al. · 2023 · Schizophrenia Research
90. Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment
    Helena Kyunghee Kim, Cameron Isaacs-Trepanier, Nika Elmi, Stanley Isaac Rapoport, Ana C. Andreazza · 2016 · Journal of Psychiatric Research
91. Important Role of Mitochondria and the Effect of Mood Stabilizers on Mitochondrial Function
    Matej Ľupták, Jana Hroudová · 2019 · Physiological Research
92. Mitochondrial Disease in 22q13 Duplication Syndrome
    Richard E. Frye · 2012 · Journal of Child Neurology
93. No evidence that major mtDNA European haplogroups confer risk to schizophrenia
    Ana Mosquera‐Miguel, Helena Torrell-Galceran, Nerea Abasolo-Zabalo, Manuel Arrojo, Eduardo Paz, Ramón Ramos‐Ríos, Santiago Agra, Mario Páramo, Julio Brenlla, Silvia Martínez et al. · 2012 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
94. Methylene Blue in the Treatment of Neuropsychiatric Disorders
    Martin Alda · 2019 · CNS Drugs
95. Higher systemic oxidatively generated DNA and RNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
    Klara Coello, Helena Lykke Bøgh, Sharleny Stanislaus, Hanne Lie Kjærstad, Sigurd Arne Melbye, Kimie Stefanie Ormstrup Sletved, Henrik Enghusen Poulsen, Maj Vinberg, Lars Vedel Kessing · 2021 · Free Radical Biology and Medicine
96. Is there a role for curcumin in the treatment of bipolar disorder?
    Elisa Macedo Brietzke, Rodrigo Barbachan Mansur, André Zugman, Andre Ferrer Carvalho, Danielle S. Macêdo, Danielle S. Cha, Vanessa Costhek Abílio, Roger S. McIntyre · 2013 · Medical Hypotheses
97. Genome-scale metabolic modelling predicts biomarkers and therapeutic targets for neuropsychiatric disorders
    S.T.R. Moolamalla, Palakkad Krishnan Unni Vinod · 2020 · Computers in Biology and Medicine
98. Treatment-resistant schizophrenia: focus on the transsulfuration pathway
    Thomas M. Berry, Eid Abo Hamza, Ahmed A. Moustafa · 2019 · Reviews in the Neurosciences
99. Pluripotent stem cells as a model to study oxygen metabolism in neurogenesis and neurodevelopmental disorders
    Bruna da Silveira Paulsen, Mariana S. Silveira, Antônio Galina, Stevens Kastrup Rehen · 2012 · Archives of Biochemistry and Biophysics
100. Neuropsychiatric Features in Primary Mitochondrial Disease
     Samantha E. Marin, Russell P. Saneto · 2015 · Neurologic Clinics